U.S. Biotechnology Instruments Market Size, Share & Growth Report, 2033
The U.S. biotechnology instruments market size was estimated at USD 34.95 billion in 2023 and is expected to be worth around USD 49.11 billion by 2033, poised to grow at a compound annual growth rate (CAGR) of 3.46% during the forecast period 2024 to 2033.
The high demand and affordability of biotechnology instrumentation. Moreover, inclination toward manual automation in biotechnology, pharmaceuticals, and related industries in this area is projected to boost the demand for advanced & sophisticated instruments to ease & accelerate process.
Furthermore, the presence of local companies and easy availability of government funding for research are anticipated to boost the market. High adoption of point-of-care diagnostic devices and continuous advancements in R&D have enhanced the capabilities of point-of-care testing systems. Moreover, novel POC devices allow real-time transmission of test results to patient's electronic medical records for easy review by physicians. The systems have also been designed to comply with changes in laboratory regulations easily.
The rising prevalence of chronic disorders, including infectious diseases, cardiovascular disorders, diabetes, cancer, and others, is expected to propel market growth. High unmet medical needs for cardiovascular diseases and increasing patient awareness are expected to boost the demand for IVD instruments. An increase in the adoption of unhealthy habits, such as smoking, a rise in the incidence of obesity, and dietary irregularities are responsible for the increase in prevalence of cardiovascular diseases. Moreover, the prevalence of diabetes is increasing, widening the patient pool.
The U.S. biotechnology instruments market accounted for 41% of the global biotechnology instruments market in 2023. This can be attributed mainly to the growing demand for automation in industrial and clinical settings. Automation in the industrial workplace has enabled companies to maximize output and profits, whereas laboratory automation in clinical settings has increased speed & reliability of patient data. A report stated that biotech startups offer on-demand experimental automation and outsourcing scientific research & development services. Such initiatives have improved the accessibility of automation services at the industrial level, boosting the market.
| Report Attribute | Details |
| Market Size in 2024 | USD 36.16 Billion |
| Market Size by 2033 | USD 49.11 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 3.46% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Product, end-use |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Thermo Fisher Scientific, Inc., Waters Corp., Shimadzu Corp., Danaher, Agilent Technologies, Inc., Bruker Corp., PerkinElmer, Inc., Mettler Toledo, Zeiss Group, Bio-Rad Laboratories, Inc., Illumina, Inc., Eppendorf SE, F. Hoffmann-La Roche AG, Sartorius AG, and Avantor, Inc. |
Based on product, analytical instruments accounted for the largest market share of 65.9% in 2023. These instruments comprise advanced technologies including chromatography, mass spectrometry, and spectroscopy that are vital for enabling analysis and characterization accuracy of biological samples. Their extensive use highlights their importance in biotechnology sector’s progress which is making substantial contributions to research, advancement, and ingenuity.
The cell culture instruments segment is expected to grow at the fastest CAGR during the forecast period. Bioreactors, and incubators media are significant tools that enables the cultivation and manipulation of cells across diverse fields including drug development, and tissue engineering. The surge in demand for personalized medicine and escalating importance of cell-based therapies are propelling the growth.
Based on end use, pharmaceutical & biotechnology companies dominated the biotechnology instruments market with a market share of 40.11% in 2023. Biotechnological instruments are used in pharmaceutical industry for experimentation, testing, and analysis. Companies are engaging capital in R&D programs owing to the growing demand for rapid drug development and commercialization of new drug molecules for the treatment of different diseases.
The academic & research industries segment is expected to grow at the fastest CAGR of 5.08% from 2024 to 2033. Several academic and research institutions are adopting a wide variety of biotechnology instruments such as DNA synthesizers, and microarray systems. The growth is driven by a surge in interdisciplinary research, collaborations, and breakthrough discoveries across fields like genomics, proteomics, and synthetic biology. These efforts are expected to emphasize innovation and consequently accelerate drug research and development.
Some prominent U.S. biotechnology instruments market companies include Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche Ltd.; Agilent Technologies; Bio-Rad Laboratories, Inc.; Illumina, Inc.; Waters Corp.; Danaher; Avantor, Inc.; and Shimadzu Corp. Companies are engaged in continuous development of advanced tools for life sciences research.
Biotechnology instruments have gained significant attention in recent years. This can be attributed to the expanding pool of companies coupled with the need to incorporate advanced instrumentation across different workflows in the biotechnology industry.
U.S. Biotechnology Instruments Market Top Key Companies:
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Biotechnology Instruments market.
By Product
By End-use
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. End-use Segment
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. U.S. Market: CAGR Calculation
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing Demand for Analytical Instruments
3.3.2. Growing Prevalence of Target Diseases and Rising Geriatric Population
3.3.3. Technological Advancements in Research-Use Instruments
3.4. Market Restraint Analysis
3.4.1. Higher Cost of Devices
3.4.2. Shortage Of Skilled Professionals
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Biotechnology Instruments Market: Product Movement Analysis
4.2. Analytical Instruments
4.2.1. Analytical Instruments Market, 2021 - 2033
4.2.2. Polymerase Chain Reaction
4.2.2.1. Polymerase Chain Reaction, 2021 - 2033
4.2.3. Spectroscopy
4.2.3.1. Spectroscopy, 2021 - 2033
4.2.4. Microscopy
4.2.4.1. Microscopy, 2021 - 2033
4.2.5. Chromatography
4.2.5.1. Chromatography, 2021 - 2033
4.2.6. Flow Cytometry
4.2.6.1. Flow Cytometry, 2021 - 2033
4.2.7. Sequencing
4.2.7.1. Sequencing, 2021 - 2033
4.2.8. Microarray
4.2.8.1. Microarray, 2021 - 2033
4.2.9. Others
4.2.9.1. Others, 2021 - 2033
4.3. Cell Culture Instruments
4.3.1. Cell Culture Instruments Market, 2021 - 2033
4.3.2. Culture Systems
4.3.2.1. Culture Systems Market, 2021 - 2033
4.3.3. Incubators
4.3.3.1. Incubators Market, 2021 - 2033
4.3.4. Cryostorage Equipment
4.3.4.1. Cryostorage Equipment Market, 2021 - 2033
4.3.5. Biosafety Equipment
4.3.5.1. Biosafety Equipment Market, 2021 - 2033
4.3.6. Pipetting Instruments
4.3.6.1. Pipetting Instruments Market, 2021 - 2033
4.4. Cell Separation Instruments
4.4.1. Cell Separation Instruments Market, 2021 - 2033
4.4.2. Centrifuge
4.4.2.1. Centrifuge Market, 2021 - 2033
4.4.3. Filtration Systems
4.4.3.1. Filtration Systems Market, 2021 - 2033
4.4.4. Magnetic-activated Cell Separator Systems
4.4.4.1. Magnetic-activated Cell Separator Systems Market, 2021 - 2033
4.5. Immunoassay Instruments
4.5.1. Immunoassay Instruments Market, 2021 - 2033
4.6. Clinical Chemistry Analyzers
4.6.1. Clinical Chemistry Analyzers Market, 2021 - 2033
4.7. Others
4.7.1. Others Market, 2021 - 2033
Chapter 5. End-use Business Analysis
5.1. Biotechnology Instruments Market: End-use Movement Analysis
5.2. Pharmaceutical & Biotechnology Companies
5.2.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033
5.3. Hospitals & Diagnostic Laboratories
5.3.1. Hospitals & Diagnostics Laboratories Market, 2021 - 2033
5.4. Academic & Research Institutes
5.4.1. Academic & Research Institutes Market, 2021 - 2033
5.5. Others
5.5.1. Others Market, 2021 - 2033
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Strategy Mapping
6.3. Company Market Share Analysis, 2023
6.4. Company Profiles/Listing
6.4.1. Thermo Fisher Scientific, Inc.
6.4.1.1. Company Overview
6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. Waters Corp.
6.4.2.1. Company Overview
6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Shimadzu Corp.
6.4.3.1. Company Overview
6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. Danaher
6.4.4.1. Company Overview
6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. Agilent Technologies, Inc.
6.4.5.1. Company Overview
6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. Bruker Corp.
6.4.6.1. Company Overview
6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. PerkinElmer, Inc.
6.4.7.1. Company Overview
6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Mettler Toledo
6.4.8.1. Company Overview
6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives
6.4.9. Zeiss Group
6.4.9.1. Company Overview
6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiatives
6.4.10. Bio-Rad Laboratories, Inc.
6.4.10.1. Company Overview
6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiatives
6.4.11. Illumina, Inc.
6.4.11.1. Company Overview
6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic Initiatives
6.4.12. Eppendorf SE
6.4.12.1. Company Overview
6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic Initiatives
6.4.13. F. Hoffmann-La Roche AG
6.4.13.1. Company Overview
6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic Initiatives
6.4.14. Sartorius AG
6.4.14.1. Company Overview
6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.14.3. Product Benchmarking
6.4.14.4. Strategic Initiatives
6.4.15. Avantor, Inc.
6.4.15.1. Company Overview
6.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.4.15.3. Product Benchmarking
6.4.15.4. Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers